Can targeted radiation boost prostate cancer control?
NCT ID NCT03556904
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether adding focused radiation to standard hormone therapy or chemotherapy helps men with prostate cancer that has spread to a few spots (oligometastatic) and is no longer responding to hormone therapy alone. Fourteen participants received either standard treatment alone or standard treatment plus radiation. The goal was to see if the combination delays cancer growth or spread.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ablative radiation therapy (focused radiation) plus standard hormone therapy or chemotherapy
What this could lead to
If successful, this could show that adding focused radiation to standard treatment helps control prostate cancer that has spread to a few spots, potentially delaying progression.
What could go wrong
This is a small, early-phase trial with only 14 participants, so results may not apply broadly. The added radiation may not improve outcomes and could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan Cancer Center
Ann Arbor, Michigan, 48109, United States
-
VA Ann Arbor Healthcare System
Ann Arbor, Michigan, 48105, United States